Related Experiment Videos

Modification of helper and suppressor/cytotoxic lymphocyte subsets in mice with motor end-plate disease

Insights

Motor end-plate disease (Med) in mice involves immune system abnormalities. Both affected and carrier mice show altered T lymphocyte subsets, impacting immune function and neuromuscular disorder progression.

Area of Science:

  • Immunology
  • Neuroscience
  • Genetics

Background:

  • Motor end-plate disease (Med) in mice presents with complex immunological abnormalities.
  • These abnormalities are observed in both homozygous MedJ/MedJ mice (lethal neuromuscular disorder) and heterozygous +/MedJ mice (mild/no clinical signs).

Purpose of the Study:

  • To investigate splenic lymphocyte subsets using Lyt monoclonal antibodies in MedJ mice.
  • To further characterize the immunological dysfunctions associated with Motor end-plate disease.

Main Methods:

  • Analysis of splenic lymphocyte subsets (Lyt1+, Lyt2+) in MedJ/MedJ and +/MedJ mice (14-18 days old) and adult +/MedJ mice.
  • Comparison of lymphocyte subset levels and ratios against normal control mice.

Main Results:

  • Both MedJ/MedJ and +/MedJ young mice exhibit high Lyt1+/Lyt2+ ratios.
  • These mice have increased Lyt1+ and decreased Lyt2+ lymphocyte pools compared to normal mice.
  • Adult +/MedJ mice show recovery of normal T lymphocyte subset levels, while surviving MedJ/MedJ mice maintain high Lyt1+/Lyt2+ ratios.

Conclusions:

  • The altered T lymphocyte subset profiles in MedJ mice correlate with previously described low suppressive function.
  • The findings provide further insight into the immunological basis of Motor end-plate disease and its genetic components.
  • Persistent immune dysregulation is evident even in MedJ mice that survive the neuromuscular disorder.

Related Concept Videos